# i-80 Gold Corp.: financial statements, quarterly

IAUX · NYSE · CIK 1853962 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/iaux.md) · [Financials](/companies/iaux/financials.md) · [Filings](/companies/iaux/filings.md) · [Insiders](/companies/iaux/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/iaux/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [8.4](/filings/0001628280-25-022012.md) | [7.2](/filings/0001853962-25-000009.md) | [11.5](/filings/0001628280-25-051673.md) | [23.2 d](/filings/0001628280-26-009886.md) | [14.0](/filings/0001628280-26-034207.md) | [27.8](/filings/0001628280-26-055367.md) | [32.0](/filings/0001628280-25-051673.md) | [21.3 d](/filings/0001628280-26-009886.md) | [52.4](/filings/0001628280-26-034207.md) | [24.3](/filings/0001628280-26-055367.md) |
| Gross profit | $m | [(0.3)](/filings/0001628280-25-022012.md) | [(12.3)](/filings/0001853962-25-000009.md) | [(4.9)](/filings/0001628280-25-051673.md) | [1.8 d](/filings/0001628280-26-009886.md) | [2.9](/filings/0001628280-26-034207.md) | [0.8](/filings/0001628280-26-055367.md) | [3.1](/filings/0001628280-25-051673.md) | [4.7 d](/filings/0001628280-26-009886.md) | [16.1](/filings/0001628280-26-034207.md) | [8.6](/filings/0001628280-26-055367.md) |
| Operating income | $m | [(16.1)](/filings/0001628280-25-022012.md) | [(31.3)](/filings/0001853962-25-000009.md) | [(24.2)](/filings/0001628280-25-051673.md) | [(17.5) d](/filings/0001628280-26-009886.md) | [(15.8)](/filings/0001628280-26-034207.md) | [(18.8)](/filings/0001628280-26-055367.md) | [(27.8)](/filings/0001628280-25-051673.md) | [(62.1) d](/filings/0001628280-26-009886.md) | [(21.8)](/filings/0001628280-26-034207.md) | [(34.1)](/filings/0001628280-26-055367.md) |
| Interest expense | $m | [8.0](/filings/0001628280-25-022012.md) | [8.3](/filings/0001853962-25-000009.md) | [8.2](/filings/0001628280-25-051673.md) | [7.9 d](/filings/0001628280-26-009886.md) | [8.2](/filings/0001628280-26-034207.md) | [7.8](/filings/0001628280-26-055367.md) | [7.0](/filings/0001628280-25-051673.md) | [6.5 d](/filings/0001628280-26-009886.md) | [5.9](/filings/0001628280-26-034207.md) | [6.5](/filings/0001628280-26-055367.md) |
| Income tax | $m | [0.4](/filings/0001628280-25-022012.md) | [0.4](/filings/0001853962-25-000009.md) | [0.4](/filings/0001628280-25-051673.md) | [0.3 d](/filings/0001628280-26-009886.md) | [0.0](/filings/0001628280-26-034207.md) | [0.0](/filings/0001628280-26-055367.md) | [0.0](/filings/0001628280-25-051673.md) | [(3.3) d](/filings/0001628280-26-009886.md) | [1.2](/filings/0001628280-26-034207.md) | [2.5](/filings/0001628280-26-055367.md) |
| Net income | $m | [(19.7)](/filings/0001628280-25-051673.md) | [(41.0)](/filings/0001628280-25-051673.md) | [(43.1)](/filings/0001628280-25-051673.md) | [(17.7) d](/filings/0001628280-26-009886.md) | [(41.2)](/filings/0001628280-26-055367.md) | [(30.2)](/filings/0001628280-26-055367.md) | [(41.9)](/filings/0001628280-25-051673.md) | [(85.6) d](/filings/0001628280-26-009886.md) | [(78.6)](/filings/0001628280-26-055367.md) | [(52.5)](/filings/0001628280-26-055367.md) |
| Diluted EPS | $ per share | [(0.06)](/filings/0001628280-25-022012.md) | [(0.11)](/filings/0001853962-25-000009.md) | [(0.11)](/filings/0001628280-25-051673.md) | not reported | [(0.10)](/filings/0001628280-26-034207.md) | [(0.05)](/filings/0001628280-26-055367.md) | [(0.05)](/filings/0001628280-25-051673.md) | not reported | [(0.09)](/filings/0001628280-26-034207.md) | [(0.06)](/filings/0001628280-26-055367.md) |
| Basic EPS | $ per share | [(0.06)](/filings/0001628280-25-022012.md) | [(0.11)](/filings/0001853962-25-000009.md) | [(0.11)](/filings/0001628280-25-051673.md) | not reported | [(0.10)](/filings/0001628280-26-034207.md) | [(0.05)](/filings/0001628280-26-055367.md) | [(0.05)](/filings/0001628280-25-051673.md) | not reported | [(0.09)](/filings/0001628280-26-034207.md) | [(0.06)](/filings/0001628280-26-055367.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2022 (2022-12-31) | FY2023 (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [48.3](/filings/0001628280-24-010631.md) | [16.3](/filings/0001628280-25-015753.md) | [13.1](/filings/0001628280-25-022012.md) | [47.8](/filings/0001853962-25-000009.md) | [21.8](/filings/0001628280-25-051673.md) | [19.0](/filings/0001628280-26-009886.md) | [13.5](/filings/0001628280-26-034207.md) | [134](/filings/0001628280-26-055367.md) | [103](/filings/0001628280-25-051673.md) | [63.2](/filings/0001628280-26-055367.md) | [514](/filings/0001628280-26-034207.md) | [465](/filings/0001628280-26-055367.md) |
| Current assets | $m | [77.3](/filings/0001628280-24-010631.md) | [39.8](/filings/0001628280-25-015753.md) | not reported | not reported | not reported | [42.3](/filings/0001628280-26-009886.md) | [44.9](/filings/0001628280-25-022012.md) | [167](/filings/0001853962-25-000009.md) | [136](/filings/0001628280-25-051673.md) | [100](/filings/0001628280-26-055367.md) | [552](/filings/0001628280-26-034207.md) | [513](/filings/0001628280-26-055367.md) |
| Total assets | $m | [642](/filings/0001628280-24-010631.md) | [654](/filings/0001628280-25-015753.md) | not reported | not reported | not reported | [656](/filings/0001628280-26-009886.md) | [659](/filings/0001628280-25-022012.md) | [783](/filings/0001853962-25-000009.md) | [756](/filings/0001628280-25-051673.md) | [703](/filings/0001628280-26-055367.md) | [1,176](/filings/0001628280-26-034207.md) | [1,174](/filings/0001628280-26-055367.md) |
| Current liabilities | $m | [85.6](/filings/0001628280-24-010631.md) | [65.2](/filings/0001628280-25-015753.md) | not reported | not reported | not reported | [74.1](/filings/0001628280-26-009886.md) | [85.7](/filings/0001628280-25-022012.md) | [121](/filings/0001853962-25-000009.md) | [133](/filings/0001628280-25-051673.md) | [138](/filings/0001628280-26-055367.md) | [58.4](/filings/0001628280-26-034207.md) | [59.5](/filings/0001628280-26-055367.md) |
| Total liabilities | $m | [309](/filings/0001628280-24-010631.md) | [309](/filings/0001628280-25-015753.md) | not reported | not reported | not reported | [315](/filings/0001628280-26-009886.md) | [341](/filings/0001628280-25-022012.md) | [319](/filings/0001853962-25-000009.md) | [333](/filings/0001628280-25-051673.md) | [357](/filings/0001628280-26-055367.md) | [877](/filings/0001628280-26-034207.md) | [916](/filings/0001628280-26-055367.md) |
| Long-term debt | $m | [114](/filings/0001628280-25-015753.md) | [163](/filings/0001628280-25-015753.md) | not reported | not reported | not reported | [154](/filings/0001628280-26-009886.md) | [157](/filings/0001628280-25-022012.md) | [98.2](/filings/0001853962-25-000009.md) | [97.2](/filings/0001628280-25-051673.md) | [97.9](/filings/0001628280-26-055367.md) | [438](/filings/0001628280-26-034207.md) | [445](/filings/0001628280-26-055367.md) |
| Current portion of debt | $m | not reported | [31.2](/filings/0001628280-25-015753.md) | not reported | not reported | not reported | [37.8](/filings/0001628280-26-009886.md) | [40.8](/filings/0001628280-25-022012.md) | [77.6](/filings/0001853962-25-000009.md) | [78.7](/filings/0001628280-25-051673.md) | [76.8](/filings/0001628280-26-055367.md) | [0.3](/filings/0001628280-26-034207.md) | [0.7](/filings/0001628280-26-055367.md) |
| Shareholders' equity | $m | [296](/filings/0001628280-25-015753.md) | [345](/filings/0001628280-26-009886.md) | [347](/filings/0001628280-25-051673.md) | [377](/filings/0001628280-25-051673.md) | [347](/filings/0001628280-25-051673.md) | [341](/filings/0001628280-26-055367.md) | [318](/filings/0001628280-26-055367.md) | [464](/filings/0001628280-26-055367.md) | [423](/filings/0001628280-25-051673.md) | [347](/filings/0001628280-26-055367.md) | [299](/filings/0001628280-26-055367.md) | [258](/filings/0001628280-26-055367.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: ifrs-full:CurrentAssets, us-gaap:AssetsCurrent
- Total assets: ifrs-full:Assets, us-gaap:Assets
- Current liabilities: ifrs-full:CurrentLiabilities, us-gaap:LiabilitiesCurrent
- Total liabilities: ifrs-full:Liabilities, us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt, us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(25.2)](/filings/0001628280-25-022012.md) | [(24.6)](/filings/0001853962-25-000009.md) | [(23.5)](/filings/0001628280-25-051673.md) | [(9.2) d](/filings/0001628280-26-009886.md) | [(22.7)](/filings/0001628280-26-034207.md) | [(11.3)](/filings/0001628280-26-055367.md) | [(15.2)](/filings/0001628280-25-051673.md) | [(34.3) d](/filings/0001628280-26-009886.md) | [(45.1)](/filings/0001628280-26-034207.md) | [(49.6)](/filings/0001628280-26-055367.md) |
| Capital expenditure | $m | [0.7](/filings/0001628280-25-022012.md) | [0.5](/filings/0001853962-25-000009.md) | [0.3](/filings/0001628280-25-051673.md) | [0.5 d](/filings/0001628280-26-009886.md) | [0.4](/filings/0001628280-26-034207.md) | [1.1](/filings/0001628280-26-055367.md) | [3.3](/filings/0001628280-25-051673.md) | [4.9 d](/filings/0001628280-26-009886.md) | [11.9](/filings/0001628280-26-034207.md) | [21.5](/filings/0001628280-26-055367.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [305](/filings/0001628280-25-022012.md) | [361](/filings/0001853962-25-000009.md) | [386](/filings/0001628280-25-051673.md) | [431](/filings/0001628280-26-034207.md) | [608](/filings/0001628280-26-055367.md) | [816](/filings/0001628280-25-051673.md) | [837](/filings/0001628280-26-034207.md) | [861](/filings/0001628280-26-055367.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 865,901,683 at 2026-08-10, from the cover of the [10-Q filed 2026-08-10](/filings/0001628280-26-055367.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.